Theravance Biopharma

Business Services · California, United States · 51-200 Employees

View Company Info for Free

Overview

Headquarters

901 Gateway Blvd, South San Francisco, C...

Phone Number

(650) 808-6000

Revenue

$104.3 Million

Stock Symbol

TBPH

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
2
2
1

About Theravance Biopharma

Theravance Biopharma, Inc. (\Theravance Biopharma\") is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. The company was founded in 2013 and is headquartered in South San Francisco, California."Explore more
Theravance Biopharma's Social MediaPopular SearchesTheravance Respiratory Company LLCTheravance BioPharmaTheravance IncTheravance Biopharma IncTheravance Biopharma US IncSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: TBPHShow more

Theravance Biopharma Org Chart

RW
United States flag for contact location.

Chief Executive Officer

PhoneEmail
AS
United States flag for contact location.

Chief Financial Officer & Senior VP, Operatio...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
BN
United States flag for contact location.

Corporate Controller

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Theravance Biopharma your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Theravance Biopharma

Compare insights from companies similar to Theravance Biopharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Theravance Biopharma

$104.3M
51-200
Public
$1.3B
2013
$389.3M
51-200
Public
$1.4B
1998
JM
John MinardoChief Legal Officer
$221.7M
201-500
Private
$480M
2005
MH
Michael HornbuckleCentral Area Executive Director, Sales
$89.5M
51-200
Public
$177.8M
2016
Jingsong Wang, Founder & Chief Executive Officer at Harbour BioMed
Jingsong WangFounder & CEO
$52.1M
201-500
Public
$372.7M
2006
Pravin Dugel, Executive Chair, President, and Chief Executive Officer at Ocular Therapeutix
Pravin DugelExecutive Chair, President, and CEO
$25.7M
51-200
Private
-
2000
Edward Wajer, Chief Executive Officer Ambit LLC - at Ambit Biosciences
Edward WajerCEO Ambit LLC -
$7.5M
501-1,000
Public
$1.4B
2014
DC
Deya CorzoChief Medical Officer, -Residence
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Theravance Biopharma is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Theravance Biopharma is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Theravance Biopharma.

Theravance Biopharma financials insights

Gather financial insights about Theravance Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2015

Share Placement

$55M

2016

Multiple Rounds

$407.8M

2018

Debt

$250M

2020

Stock Offering

$148.5M

Debt

$400M

See All Theravance Biopharma's Financials Insights

Theravance Biopharma Tech Stack

A closer look at the technologies used by Theravance Biopharma

Most Recent Scoops

Project
Theravance Biopharma has entered into a commercial arrangement with Viatris and Theravance Biopharma under which Zymeworks will receive a 35% participation in US net profits from YUPELRI, with Viatris responsible for community promotion and Theravance managing the hospital setting.
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Divestiture
Theravance Biopharma has completed the sale of its remaining royalty interest in Trilogy to GSK for $225 million. This transaction significantly strengthens Theravance Biopharma's balance sheet and represents the first major outcome from its strategic review committee's efforts to unlock shareholder value.
Divestitures, Business Finance, Corporate Strategy, Finance
Project
reported that the Cypress trial for AMPRELOX was designed in collaboration with FDA to confirm benefits observed in Study 170 in a larger population of patients with MSA. The trial uses a randomized withdrawal design and includes an enrichment strategy to identify patients showing clear symptom benefits during the open label phase.
Research & Development, Pharmaceuticals, Clinical Operations
Earnings
Earnings, Accounting, Sales, Financial Reporting, Finance
See more scoops

Theravance Biopharma News & Media

Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Theravance Biopharma

What is Theravance Biopharma's stock symbol?
Theravance Biopharma's stock symbol is TBPH
What is Theravance Biopharma's official website?
Theravance Biopharma's official website is www.theravance.com
What is Theravance Biopharma's Revenue?
Theravance Biopharma's revenue is $104.3 Million
What is Theravance Biopharma's SIC code?
Theravance Biopharma's SIC: 87,873
What is Theravance Biopharma's NAICS code?
Theravance Biopharma's NAICS: 54,541
How many employees does Theravance Biopharma have?
Theravance Biopharma has 51-200 employees
What industry does Theravance Biopharma belong to?
Theravance Biopharma is in the industry of: Business Services, Research & Development
What is Theravance Biopharma competition?
Theravance Biopharma top competitors include: Ambit Biosciences, Ironwood Pharmaceuticals, Roivant, Harbour BioMed
What companies has Theravance Biopharma acquired?
Theravance Biopharma has acquired the companies: Theravance Biopharma, Kairos Therapeutics
What technology does Theravance Biopharma use?
Some of the popular technologies that Theravance Biopharma uses are: Microsoft IIS, Freshservice, Zingfit, DocuSign
Who is the CFO of Theravance Biopharma?
Theravance Biopharma's CFO is Aziz Sawaf
How do I contact Theravance Biopharma?
Theravance Biopharma contact info: Phone number: (650) 808-6000 Website: www.theravance.com
What does Theravance Biopharma do?

Theravance Biopharma, Inc. (\Theravance Biopharma\") is a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines. The company was founded in 2013 and is headquartered in South San Francisco, California."... Read More

What are Theravance Biopharma social media links?
Theravance Biopharma Linkedin page Theravance Biopharma Twitter page
Is Theravance Biopharma a public company?
Yes, Theravance Biopharma is a public company and is traded under the symbol TBPH
See more information about Theravance Biopharma

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.